These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20850896)

  • 1. Risk factors for multidrug-resistant bacterial infection among patients with tuberculosis.
    Kim HR; Hwang SS; Kim EC; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    J Hosp Infect; 2011 Feb; 77(2):134-7. PubMed ID: 20850896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for multidrug-resistant tuberculosis in Hong Kong.
    Law WS; Yew WW; Chiu Leung C; Kam KM; Tam CM; Chan CK; Leung CC
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1065-70. PubMed ID: 18713506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The background of drug-resistant tuberculosis patients on the basis of the annual report database for 2007-2009 in Japan].
    Ohmori M; Shimouchi A; Ito K; Uchimura K; Yoshiyama T; Mitarai S
    Kekkaku; 2012 Apr; 87(4):357-65. PubMed ID: 22702084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis.
    Teixeira L; Perkins MD; Johnson JL; Keller R; Palaci M; do Valle Dettoni V; Canedo Rocha LM; Debanne S; Talbot E; Dietze R
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):321-8. PubMed ID: 11334250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for multidrug-resistant tuberculosis in four centers in Burkina Faso, West Africa.
    Diandé S; Sangaré L; Kouanda S; Dingtoumda BI; Mourfou A; Ouédraogo F; Sawadogo I; Nébié B; Gueye A; Sawadogo LT; Traoré AS
    Microb Drug Resist; 2009 Sep; 15(3):217-21. PubMed ID: 19728781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent nosocomial transmission and genotypes of multidrug-resistant Mycobacterium tuberculosis.
    Nodieva A; Jansone I; Broka L; Pole I; Skenders G; Baumanis V
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):427-33. PubMed ID: 20202300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil.
    Brito RC; Mello FC; Andrade MK; Oliveira H; Costa W; Matos HJ; Lourenço MC; Rolla VC; Fonseca L; Ruffino Netto A; Kritski AL
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):24-33. PubMed ID: 20003691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province, China].
    Wang GJ; Xu JY; Wang GB; Zhen XA; Gao SY; Du CM
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):527-30. PubMed ID: 17074265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multidrug-resistant tuberculosis. Additional comment: primary multidrug-resistant tuberculosis--diagnosis and treatment].
    Tsuyuguchi K
    Kekkaku; 1998 Nov; 73(11):687-90. PubMed ID: 9866932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients.
    Podewils LJ; Holtz T; Riekstina V; Skripconoka V; Zarovska E; Kirvelaite G; Kreigere E; Leimane V
    Epidemiol Infect; 2011 Jan; 139(1):113-20. PubMed ID: 20429966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical research on multi-drug resistant and extensive drug-resistant tuberculosis in Japan].
    Toyota E; Kawabe Y; Yotsumoto H; Sakatani M; Tsuyuguchi K; Maekura R; Fujikawa K; Takashima T; Ogawa K; Yoshiyama T; Sugie T
    Kekkaku; 2008 Dec; 83(12):773-7. PubMed ID: 19172822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for nosocomial transmission of multidrug-resistant tuberculosis due to Mycobacterium bovis among HIV-infected patients.
    Cobo J; Asensio A; Moreno S; Navas E; Pintado V; Oliva J; Gómez-Mampaso E; Guerrero A
    Int J Tuberc Lung Dis; 2001 May; 5(5):413-8. PubMed ID: 11336271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for multidrug-resistant tuberculosis in Diyarbakir, Turkey.
    Tanrikulu AC; Abakay A; Abakay O
    Med Sci Monit; 2010 Jun; 16(6):PH57-62. PubMed ID: 20512101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.